Skip to main content

ZYUS Life Sciences Announces Cancellation of LIFE Offering and Launch of Private Placement

Newswire.ca - Tue Feb 24, 9:39PM CST

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

SASKATOON, SK, Feb. 24, 2026 /CNW/ - ZYUS Life Sciences Corporation (the "Company") (TSXV: ZYUS), a clinical stage life sciences company focused on the development and commercialization of novel non‑opioid drug candidates for pain management, today announces the Company has elected to cancel its previously announced brokered private placement offering (the "LIFE Offering"), which was originally announced on January 12, 2026 and amended and restated on February 9, 2026. As a result, no securities will be issued, and the Company will not receive any proceeds from the offering.

Read more at newswire.ca

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).